Previous Article | Next Article 
Journal of Virology, November 1998, p. 9181-9191, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Pseudorabies Virus-Induced Leukocyte Trafficking
into the Rat Central Nervous System
Stefanie
Rassnick,1,*
Lynn W.
Enquist,2
Alan F.
Sved,1 and
J. Patrick
Card1
Department of Neuroscience, University of
Pittsburgh, Pittsburgh, Pennsylvania 15260,1
and
Department of Molecular Biology, Princeton University,
Princeton, New Jersey 085442
Received 30 March 1998/Accepted 20 July 1998
 |
ABSTRACT |
When the swine alphaherpesvirus pseudorabies virus (PRV) infects
the rat retina, it replicates in retinal ganglion cells and invades the
central nervous system (CNS) via anterograde transynaptic spread
through axons in the optic nerve. Virus can also spread to the CNS via
retrograde transport through the oculomotor nucleus that innervates
extraocular muscles of the eye. Since retrograde infection of the CNS
precedes anterograde transynaptic infection, the temporal sequence of
infection of the CNS depends on the route of invasion. Thus, motor
neurons are infected first (retrograde infection), followed by CNS
neurons innervated by the optic nerve (anterograde transynaptic
infection). This temporal separation in the appearance of virus in
separate groups of neurons enabled us to compare the immune responses
to different stages of CNS infection in the same animal. The data
revealed focal trafficking of peripheral immune cells into areas of the
CNS infected by retrograde or anterograde transport after PRV Becker
was injected into the vitreous body of the eye. Cells expressing the
leukocyte common antigen, CD45+, entered the area of
infection from local capillaries prior to any overt expression of
neuropathology, and quantitative analysis demonstrated that the number
of cells increased in proportion to the number of infected neurons
within a given region. Recruitment of cells of monocyte/macrophage
lineage began prior to the appearance of CD8+ cytotoxic
lymphocytes, which were, in turn, followed by CD4+
lymphocytes. These data demonstrate that PRV replication in CNS neurons
stimulates the focal infiltration of specific classes of
CD45+ cells in a time-dependent, temporally organized
fashion that is correlated directly with the number of infected neurons
and the time that a given region has been infected.
 |
INTRODUCTION |
In recent years, it has become
increasingly apparent that cells of hematopoietic origin play an
integral role in the response of the nervous system to neurotropic
viral infections (for recent reviews, see references 10,
23, and 52). The early work of Townsend
(62) demonstrated a reduction in herpes simplex virus type 1 (HSV-1)-induced demyelinating central nervous system (CNS) lesions in
nude mice compared to that in intact controls. Thereafter, Simmons and
Tscharke (51) showed that HSV-1-induced neuronal destruction
in the peripheral nervous system increased in mice depleted of CD8
lymphocytes, suggesting that these lymphocytes are essential in the
clearance of virus. A number of subsequent studies demonstrated
trafficking of peripheral immune cells into CNS in response to viral
infection but reported differing roles for these cells. For example,
Subak-Sharpe and colleagues (57) showed that the depletion
of CD8+ cytotoxic lymphocytes does not alter the
invasiveness or spread of Semliki Forest virus through the CNS but does
prevent the demyelinating lesions that occur in intact animals.
Similarly, Hudson and Streilein (27) demonstrated that
accumulation of lymphocytes in HSV-infected regions of mouse cerebral
cortex correlates with the appearance of focal lesions in the region of
infection. In contrast, studies examining the role of T lymphocytes in
replication, spread, and virus-induced pathogenesis of vesicular
stomatitis virus (28) and mouse hepatitis virus (58,
74) demonstrated that CD4+ and CD8+
lymphocytes are important for viral clearance but play only a minor
role in the generation of pathology. Some of these differences may be
related to unique responses to different strains of virus or the models
of infection used in the different analyses. Nevertheless, it remains
clear that trafficking of immune cells into the brain is a fundamental
response to neurotropic viral invasion.
In spite of the well-documented infiltration of immune cells into the
brain, less is known regarding the time course of recruitment of
different classes of leukocytes. Weinstein and colleagues
(70) demonstrated focal infiltration of granulocytes, T
lymphocytes, and monocytes in response to the spread of HSV through the
CNS but did not determine the kinetics of appearance of different cell
types. T-lymphocyte infiltration into HSV-infected brain tissue has
also been reported by Lewandowski and colleagues, but their focus has
been on major histocompatibility complex antigen and cytokine
expression in response to infection by different HSV strains
(34-36). Williamson and coworkers (75) isolated
and characterized a heterogeneous population of mononuclear cells recovered from the brains of mice infected with mouse hepatitis virus
and reported a temporal association between the peak incidence of
CD8+ cells and reduction of the intracerebral concentration
of virus. Similarly, an association between the directed infiltration
of cells of monocytic lineage and the development of pathological changes in PRV-infected CNS neurons has also been demonstrated (6,
46). These observations suggest that the peripheral immune system
mounts a complex multicellular response to viral infections of the CNS,
but the mechanisms that lead to the directed recruitment of immune
cells to the infection site in the CNS remain to be established.
Furthermore, the way in which this response functions to limit virus
dissemination through the CNS or to clear an infection requires a more
detailed characterization of the kinetics of immune cell recruitment in
relation to the extent of viral replication.
In the present investigation, we extended our prior analysis of the
spatial and temporal response of resident glial and immune cells to PRV
infection of the CNS (6, 46), using a well-characterized model of a viral infection in which virus enters the CNS through visual
circuitry (8, 9, 15, 73). An important feature of this
model is that viral infection of the CNS is achieved by peripheral
inoculation rather than by direct injection of the brain parenchyma.
Thus, the brain response to viral infection can be monitored over time
and cellular responses to viral replication can be evaluated in the
absence of nonspecific damage to the CNS that would result from direct
injection. Our experiments demonstrate that the number of leukocytes
entering the CNS after lethal infection with virulent PRV correlates
with the number of infected neurons and that there are differences in
the times when functionally distinct subclasses of immune cells appear
in the area of infection.
 |
MATERIALS AND METHODS |
Virus.
The virulent Becker strain of PRV was grown in a
porcine kidney cell line (PK15) in a biosafety level 2 containment
facility. Cells infected with virus were scraped into medium,
freeze-thawed, sonicated, centrifuged to clear cellular debris, and
stored frozen at
70°C (14). The number of PFU in each
viral stock was determined on PK15 cells and adjusted to
108 PFU/ml. Aliquots of virus were thawed immediately prior
to use.
Animals and inoculations.
Twenty-three male Sprague-Dawley
rats (Harlan Sprague Dawley, Indianapolis, Ind.) weighing 282 ± 11 g (mean ± standard error of the mean) at the
time of injection were used in this study. The rats were housed in
a biosafety level 2 containment laboratory that met specific safety
regulations required for experiments using an NIH/CDC class
II pathogen (7). The rats were housed two per cage in a
constant photoperiod (12 h light-12 h dark; light on at 0700) and
provided with unlimited access to food and water. All rats were
allowed to acclimate to the animal facility for at least 3 days prior
to any experimental procedure. Procedures used for the maintenance and
use of experimental animals complied with the regulations described in
the NIH Guide for the Care and Use of Laboratory Animals and were
reviewed and approved by the University of Pittsburgh and Princeton
University Animal Care and Use Committees.
Experimental animals (n = 19) were anesthetized with
xylazine (7 mg/kg) and ketamine (60 mg/kg), and then 2 µl of PRV
Becker was injected into the vitreous body of the right eye (at a rate of 1 µl/min) with a Hamilton microliter syringe fitted with a 26-gauge needle. The needle was left in place for 5 min following injection of the inoculum. Control rats received identical injections of either 2% fetal bovine serum (FBS) in Dulbecco's modified Eagle's medium (DMEM; n = 2 rats) or mock-infected medium (2%
FBS in DMEM that was incubated with virus-free PK15 cells for 72 h; n = 2 rats). The rats were returned to their home
cage, where they remained until the time of perfusion. All injections
occurred during the light phase of the photoperiod.
Perfusion fixation and tissue preparation.
At various times
after inoculation (for virus-injected rats, 51 to 52 h
[n = 5], 70 to 80 h [n = 11],
and 80 to 89 h [n = 3]; for control animals,
74 h [n = 4]), the rats were anesthetized with
an overdose of ketamine and perfused transcardially with isotonic
saline, followed by 4% paraformaldehyde containing lysine and sodium
metaperiodate (39). The brains were removed, postfixed for
1 h at 4°C, and cryoprotected with phosphate-buffered 20% sucrose solution at 4°C for at least 24 h. Coronal sections of brain tissue (35-µm thick) were cut with a freezing microtome and
stored in a cryoprotectant medium at
20°C (69) prior to immunohistochemical localization of viral antigen or leukocytes.
Antibodies.
Viral structural proteins were detected by using
a rabbit polyvalent antiserum (Rb134) that was generated against
acetone-inactivated PRV virions (7). Mononuclear lymphocytes
were detected with a mouse monoclonal antibody to rat leukocyte common
antigen (anti-CD45; Pharmingen, San Diego, Calif.); CD45 is expressed
on all hematopoietic cells (except erythrocytes) as well as microglia.
Mononuclear phagocytes were detected with a mouse monoclonal antibody
(ED-1; Bioproducts for Science, Indianapolis, Ind.) that recognizes a cytoplasmic antigen expressed by rat monocytes and macrophages (13). Cytolytic T lymphocytes were detected with a mouse
monoclonal antibody (anti-CD8
; Pharmingen) generated against the
chain of the rat CD8 antigen which is expressed on cytotoxic T
lymphocytes but is absent on natural killer cells
(61). T-helper lymphocytes were detected
with a mouse monoclonal antibody (OX-38; Pharmingen) that recognizes
rat CD4 antigen. OX-38 recognizes the same epitope of CD4 as W3/25, and
these antibodies have been reported to also recognize CD4
expressed on rat macrophages and rat microglia (30, 43, 67).
Immunocytochemical localizations.
The avidin-biotin
modification of the immunoperoxidase procedure (26) was used
to localize all antigens. Sections at a minimum frequency of 280 µm
were incubated free-floating in primary antibody overnight at 4°C at
the following dilutions: Rb134, 1:10,000; anti-CD45, 1:1,000; ED-1,
1:1,000; anti-CD8
, 1:500; anti-CD4, 1:1,000. Species-specific
affinity-purified secondary antibodies (Jackson ImmunoResearch
Laboratories) and Vectastain reagents (Vectastain Elite Kit; Vector
Laboratories) were used to complete the immunohistochemical processing
in accordance with published procedures (5). Processed
sections were mounted on gelatin-coated glass slides, dehydrated with a
series of graded ethanols, and cleared in xylene, and cover- glasses
were fixed with Cytoseal 60 (VWR Scientific, Cleveland, Ohio). Staining
for CD4+ cells was not performed on brain tissue from 3 of
the 19 virus-infected rats because there was no more tissue available
from these brains.
Data analysis.
The organization of the neuronal circuitry
analyzed in this study is shown in Fig.
1. Quantitative determinations of the
number of infected neurons and cells immunopositive for CD45, ED-1,
CD8
, or CD4 antigens were made for motor neurons in the oculomotor nucleus ipsilateral to the injected eye and two retinorecipient regions
(the suprachiasmatic nucleus [SCN] and the dorsolateral geniculate
nucleus [DGN]) contralateral to the injected eye. Immunoreactive cells in the SCN and DGN contralateral to the injected eye were counted
because more than half of the rat retinal ganglion cell axons cross to
innervate the opposite side of the brain. As a result, the number of
infected neurons in visual centers such as the SCN, geniculate nuclei,
and tectum are always greater in the side opposite to the
injected eye (9). In contrast, the innervation of
extraocular eye muscles originates from motor neurons ipsilateral to
the eye.

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 1.
A schematic illustration of the organization of the
neuronal circuitry that was the subject of analysis in this
investigation is shown at the top of the figure. Filled boxes represent
areas that were included in the analysis, while open boxes represent
motor nuclei that were virus infected but not subjected to analysis in
this study. Injections of virus into the vitreous body of the eye
produced an anterograde transynaptic infection of retinorecipient
neurons in the diencephalon (SCN and geniculate complex) and midbrain
(tectum). The distribution of infected neurons in these regions at long
postinoculation intervals after injection of PRV Becker is illustrated
in the photomicrographs of the SCN (A), the geniculate complex that
includes the DGN and IGL (B), and the tectum (C). Leakage of virus into
the eye also produced a retrograde infection of motor neurons
innervating eye musculature (oculomotor, trochlear, and abducens
nuclei). dmSCN, dorsomedial suprachiasmic nucleus; vlSCN, ventrolateral
suprachiasmic nucleus.
|
|
Cell counts were obtained by preparing camera lucida drawings that
defined the number and distribution of immunopositive cells
in each
area. To ensure accurate comparisons between animals,
we selected
comparable coronal planes of a section midway through
the linear extent
of each nucleus. The numbers of virus-infected
neurons and leukocytes
in brain sections of every infected rat
were then counted. For each
virus-infected rat, and each defined
area of infection, the number of
CD45
+, ED-1
+, CD8
+, or
CD4
+ leukocytes was paired with the number of
virus-infected neurons
for that rat within that area of infection.
Because leukocyte
recruitment was the key variable about which
predictions were
to be made, the numbers of leukocytes were placed on
the ordinate
and the numbers of infected neurons were placed on the
abscissa
when graphs were made. These variable pairs were plotted as
scatterplots.
That is, the number of CD45
+,
ED-1
+, CD4
+, or CD8
+ cells
counted within an area of infection were plotted as a function
of the
number of virus-infected neurons counted within that region,
and the
best-fitting line of the data was generated by using regression
analysis. Thus, each data point in Fig.
6 and
7 represents the
data
used in separate analyses for each brain region and each
leukocyte
subtype. Plots of linear regression lines for these
data indicated that
the relation between leukocyte infiltration
and viral infection was
best described by fitting curvilinear
regression lines generated with
polynomial functions. The polynomial
equation for each analysis was
empirically determined by adding
increasing powers of
x
(i.e.,
x2 and
x3 for a
cubic equation) and the associated regression coefficient
(slope
factor) to best fit each set of data (
53). The corresponding
polynomial curve was drawn by using these equations. The degree
of
association between leukocyte infiltration and viral infection
was
determined by using the coefficient of determination
(
r2); greater values of
r2 indicate a higher degree of association
between leukocyte infiltration
and viral infection.
 |
RESULTS |
PRV Becker produced a predictable course of CNS infection.
Consistent with previous studies (8, 9, 15, 73), injection
of PRV Becker into the vitreous body of the eye infected different
visual centers in the brain (Fig. 1) at two time points separated by
approximately 24 h. The progression of infection through this
circuitry was marked by the sequential infection of neurons
involved in visual perception (DGN) and reflex movement of the eyes (tectum) approximately 50 h after
inoculation, followed by areas of brain involved in the temporal
(circadian) organization of behavior (SCN and intergeniculate
leaflet [IGL]) at approximately 72 h. Motor neurons in the
oculomotor nucleus were infected within 52 h of inoculation by the
retrograde transport of PRV that had leaked into the orbit. The data
also confirmed the cytopathic effects of this virulent PRV strain on
CNS neurons (6, 9, 46). Neuropathological changes were noted
shortly after the onset of viral replication and became increasingly
pronounced with advancing survival.
Viral infection led to focal recruitment of immune cells into the
CNS.
Analysis of CD45 immunoreactivity in control and PRV-infected
brains revealed marked differences in the patterns of cellular staining. CD45+ leukocytes, identified as cells with a
spherical morphology (5 to 10 µm in widest diameter) and no
immunoreactive processes, were few in number (approximately 5 cells/brain) and were randomly distributed throughout the brain
after injections of mock-infected medium or 2% FBS in DMEM into the
vitreous body of the eye (data not shown). CD45+
microglia, identified by their characteristic small cell bodies and
cytoplasmic processes, were lightly stained in control
animals and widely distributed throughout the brain with no
differential concentration within any region. These patterns of
staining differed considerably from that which occurred in PRV-infected
brain tissue. Although we did not analyze the glial cell response
in the present study, the CD45+ microglia in densely
infected areas displayed a reactive morphology with characteristic
increases in the size of their perikarya and processes, consistent with
our findings in autonomic circuitry (46).
Intensely labeled CD45
+ leukocytes were differentially
concentrated in areas of viral infection. The number of these cells
correlated with the extent of infection in different retinorecipient
regions of the CNS. At early stages of infection in each brain
region
(i.e., shortly after the onset of viral replication in
neurons), the
CD45
+ cells were few in number and closely associated with
blood vessels
in the area of infection (Fig.
2B,
5B, and
5F). As the number
of
infected neurons increased within an area, the CD45
+ cells
also became more prevalent and were found throughout the
parenchyma of
the area of infection (Fig.
2F,
3B, and
4B). Figure
6A shows that there were few
CD45
+ leukocytes recruited when less than 100 oculomotor
neurons were
infected but there was a progressive increase in the
number of
CD45
+ leukocytes as the number of infected
cells approached 200. The
numbers of CD45
+ cells present in
the oculomotor nucleus were strongly correlated
with the numbers of
infected neurons in this nucleus (
r2 = 0.96).
Similiarly, the numbers of CD45
+ cells localized within
the DGN and SCN were strongly associated
with the numbers of
infected neurons in these regions (Fig.
6D
and
7A).

View larger version (79K):
[in this window]
[in a new window]
|
FIG. 2.
Localization of viral antigen and phenotypically
distinct populations of leukocytes in the oculomotor nucleus after
injection of PRV Becker into the vitreous body of the eye. At the top
of the figure are schematic drawings (modified from Swanson's brain
map computer graphics files [59]) of a sagittal view of the brain
(left) and a coronal section with an open square in the middle
indicating the location of the oculomotor nucleus (right). Micrographs
of adjacent sections of tissue that were processed with antibodies
recognizing viral, CD45, ED-1, or CD + antigen are shown
below the drawings. (A to D) Micrographs of brain tissue from a
representative rat with several virus-infected neurons. These pictures
show viral immunoreactivity in the oculomotor nucleus (A),
immunoreactive cells expressing the CD45 antigen and an enlarged view
of these cells by a blood vessel (B), ED-1+ cells (C), and
CD8 + leukocytes (D). (E to H) Micrographs of brain
tissue from a representative rat with many virus-infected neurons in
the oculomotor nucleus. This series of micrographs show viral
immunoreactivity (E), immunoreactive cells expressing the CD45 antigen
(F), ED-1+ immunoreactive cells (G), and
CD8 + leukocytes (H). Scale bar, 100 µm for all
figures. Arrows indicate blood vessels.
|
|

View larger version (162K):
[in this window]
[in a new window]
|
FIG. 3.
Localization of viral antigen and phenotypically
distinct populations of leukocytes in the DGN after injection of PRV
Becker into the vitreous body of the eye. The micrographs are of
adjacent sections of tissue from a representative animal with numerous
infected neurons in the DGN and illustrate viral immunoreactivity (A),
immunoreactivity of cells expressing the CD45 antigen (B),
ED-1+ immunoreactive cells (C), and immunoreactive
CD8 + leukocytes (D). Scale bar, 100 µm for all
figures.
|
|

View larger version (122K):
[in this window]
[in a new window]
|
FIG. 4.
Localization of viral antigen and the virus-induced
cellular infiltrate of phenotypically distinct populations of
leukocytes in the superior colliculus after injection of PRV Becker
into the vitreous body of the eye. The micrographs are of adjacent
sections of tissue from a representative animal with numerous infected
neurons in the superior colliculus and illustrate viral
immunoreactivity (A), immunoreactivity of cells expressing the CD45
antigen (B), ED-1+ immunoreactive cells (C), and
immunoreactive CD8 + leukocytes (D). Scale bar, 100 µm
for all figures.
|
|

View larger version (96K):
[in this window]
[in a new window]
|
FIG. 5.
Localization of viral antigen and phenotypically
distinct populations of leukocytes in the SCN after injection of PRV
Becker into the vitreous body of the eye. At the top of the figure are
schematic drawings of a sagittal view of the brain (left) and a coronal
section with an open square indicating the location of the SCN (right).
The micrographs are of adjacent sections of tissue from a
representative animal with several infected neurons in the SCN (A to D)
and from a representative animal with many more infected neurons in the
SCN (E to H). They illustrate viral immunoreactivity (A and E),
immunoreactivity of cells expressing the CD45 antigen (B and F),
ED-1+ immunoreactive cells (C and G), immunoreactive
CD8 + leukocytes (D and H). Scale bar, 100 µm for all
figures. Asterisks in panels A and B and arrows in panels B, F, G, and
H indicate blood vessels.
|
|

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 6.
Quantitative analyses showing the relation between
leukocyte infiltration and viral infection in the oculomotor nucleus
and DGN after injection of PRV Becker into the vitreous body of the
eye. CD45-, ED-1-, CD8 -, and CD4-immunopositive leukocytes and
neurons containing immunoreactivity to viral structural proteins were
counted in brain tissue from each virus-infected rat. The individual
data points in these figures are the actual number of cells counted for
each rat in each region of infection. These figures also show the
best-fitting curvilinear line of the data. No inferences should be made
about the shape of the end of each curve, which is based on only a few
data points. r2 indicates the strength of the
association between leukocyte infiltration and viral infection. Note
that the range of values on the x axis changes according to
the area of infection.
|
|
The CD45+ cellular infiltrate in areas of viral
infection contains distinct subclasses of immune cells.
Analysis of adjacent sections stained with antibodies recognizing
CD4, CD8
, and monocytic cells revealed that each of these subclasses of CD45+ immune cells were present in
the population of cells that entered the brain in response to PRV
infection of neurons (Fig. 2 to 7). The
numbers of cells varied directly with the number of infected neurons
within a region; the largest number of each subclass of immune cell was
always observed in areas with the most advanced infection (i.e.,
numerous infected neurons) (Fig. 2 to 7). The numbers of
ED-1+ cells and CD8
+ cells correlated well
with the number of virus-infected neurons in the oculomotor nucleus,
DGN, and SCN (r2 ranging from 0.56 to 0.94)
(Fig. 6 and 7). There were fewer CD4+ cells relative to the
other populations of cells, with only scattered cells apparent in
areas with the most advanced infection (data not shown). Almost
all of the CD4+ cells were small and spherical in
morphology, and these were counted as CD4+ lymphocytes.
There was a high degree of association between the number of
CD4+ lymphocytes and the number of infected neurons in the
oculomotor nucleus and DGN (Fig. 6C and F); because there were so few
CD4+ lymphocytes in the SCN, the association between the
extent of CD4+ lymphocyte infiltration and viral infection
in this area (Fig. 7D) was less strong than that in other regions.
Lightly stained CD4+ microglia were also present
in areas with numerous virus-infected neurons. Furthermore, the number
of CD45+ leukocytes localized within the oculomotor
nucleus, DGN, and SCN was always substantially larger than either
the ED-1+, CD8
+, or CD4+
population of cells or the sum of these distinct population of leukocytes (Fig. 6 and 7).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 7.
Quantitative analyses showing the relation between
leukocyte infiltration and viral infection in the SCN after injection
of PRV Becker into the vitreous body of the eye. CD45-, ED-1-, CD8 -,
and CD4-immunopositive leukocytes and neurons containing
immunoreactivity to viral structural proteins were counted in brain
tissue from each virus-infected rat. The individual data points in
these figures are the actual number of cells counted for each rat in
each region of infection. These figures also show the best-fitting
curvilinear line of the data. r2 indicates the
strength of the association between leukocyte infiltration and viral
infection.
|
|
There are timing differences in the recruitment of immune cell
subclasses into infected areas.
In each case, ED-1+
cells were greater in number than the CD8
+ cells in
adjacent sections from the same animal (Fig. 2 to 5 and compare Fig. 6B
and C, Fig. 6E and F, and Fig. 7B and C). Likewise, as the
number of infected neurons in each area increased, there was a
greater number of CD8
+ cells than CD4+ cells
localized within virus-infected areas (Fig. 6C and F and compare Fig.
7C and D).
The extent of leukocyte infiltration into specific virus-infected
areas paralleled the time that specific areas became infected.
Comparison of the extent of infiltration into specific areas of
infection indicated that the maximal numbers of CD45+,
ED-1+, CD8
+, and CD4+ leukocytes
localized in the SCN (Fig. 7) were less than those found in the
oculomotor nucleus and DGN (Fig. 6). Thus, the lesser extent of
leukocyte infiltration into the SCN corresponded with the later onset
of viral replication in the SCN.
 |
DISCUSSION |
Our data add, in two important ways, to a large body of literature
(see reference 23 for a recent review) demonstrating focal recruitment of a heterogeneous population of leukocytes to sites
of CNS viral infection. First, we found that the magnitude of immune
cell recruitment is dependent directly upon the extent of viral
infection within a given region. Second, we observed a temporal
segregation of functionally distinct populations of immune cells,
thereby providing insight into the possible functional significance of
different components of this response.
The trafficking of leukocytes into regions of infection occurred
irrespective of the route of viral invasion (anterograde versus
retrograde). However, there were differences in the onset of immune
cell invasion in different regions. For example, the earliest
trafficking was observed in the oculomotor nucleus, the DGN, and
the tectum. Each of these regions is characterized by viral
replication that begins approximately 48 h
postinoculation and increases rapidly thereafter. This is in contrast
to the onset of viral replication in neurons of the hypothalamic SCN
and IGL, where PRV-infected neurons cannot be detected
immunohistochemically until approximately 72 h postinoculation
(8, 9, 15, 73). Thereafter, the number of infected neurons
in each of these regions increases rapidly as virus moves
transynaptically through the short-axon, local-circuit neurons that
constitute these cell groups. The data showing a lesser extent of
leukocyte infiltration in the SCN relative to that in the oculomotor
nucleus, DGN, and tectum support the conclusion that the extent of
leukocyte infiltration into the CNS correlated with the time that
specific areas became infected. The data showing larger infiltrations
of ED-1+ cells relative to CD8
+ T cells and
the greater number of CD8
+ T cells relative to
CD4+ T cells in each area of infection at each survival
period suggested that ED-1+ cells entered infected areas
earlier than CD8
+ T cells did and that CD4+
T cells followed CD8
+ T cells.
The focal, time-dependent recruitment of lymphocytes from the
vasculature into virus-infected sites is consistent with prior investigations that have demonstrated directed recruitment of immune
cells into the brain in response to neurotropic viral infections. However, the functional consequences of this recruitment appear to vary
according to the type of viral infection and the route of viral
invasion. Compelling evidence supports the conclusion that
CD4+ and CD8+ lymphocytes participate in the
clearance of mouse hepatitis virus and vesicular stomatitis virus from
the nervous system (28, 74, 75). In contrast, T lymphocytes
have been suggested to mediate immunopathology when the cornea or CNS
is infected with an alphaherpesvirus (27, 33, 42, 47,
62-65). For example, in the corneal scarification model employed
by Kristensson et al. (33) and Townsend (62-65),
peripheral inoculation of the cornea with HSV produced a demyelinating
lesion of the centrally projecting portion of trigeminal axons that was
preceded by the sequential recruitment of macrophages and T cells to
the trigeminal root zone. The extent of this pathology was reduced in
athymic nude mice, leading Townsend to hypothesize that interactions of macrophages and T cells contribute to the pathological changes in the
central trigeminal axons. This conclusion is supported by the
demonstration that CD8+ T cells are associated with focal
CNS temporal lobe lesions in natural killer cell-deficient,
HSV-infected mice (27).
Data in support of immune cells participating in virus-induced
pathology is evident in the present results as well as those of prior
studies using PRV in this model. For example, the late recruitment of
cells of monocyte/macrophage lineage to viral infection sites observed
in the present study reproduces the previous demonstration of this
temporal association (46). Subsequent ultrastructural analysis of that response demonstrated that these cells were intimately associated with neurons in advanced stages of degeneration and appear
to contribute to the degeneration of the infected neurons (6). The present demonstration that the recruitment times of CD8+ and CD4+ T lymphocytes are similarly
delayed argues that these cells also contribute to the killing of
infected neurons. However, the mechanism through which this is achieved
and the role of these leukocytes at PRV-infected brain sites require
further investigation. The direct lytic actions of CD8+ T
lymphocytes occur after their T-cell receptor recognizes immunogenic peptide bound to major histocompatibility complex (MHC) class I
molecules on the surface of antigen-presenting cells (1, 22, 55,
58, 75, 78). The consensus is that cell surface expression of MHC
molecules occurs on glial, endothelial, and ependymal cells (2,
17, 18, 41, 48, 68, 70) but not on neurons (31, 32, 36, 41,
70). Furthermore, most herpesviruses, including PRV, encode
proteins that can inhibit MHC-viral peptide complex formation or
transport in infected cells (4, 15a, 40). These findings
suggest that CD8+ T lymphocytes may not mediate direct
cytotoxicity against PRV-infected neurons; instead, these cells may
participate in cytokine-mediated, nonlytic control of viral
replication. Further studies are needed to examine this hypothesis and
to determine whether other CNS cells serve as targets for the
CD8+ T lymphocytes that localize to PRV-infected areas.
Few CD4-positive lymphocytes were found in infected areas of the brain
even at the latest times after infection. Therefore, it is difficult to
ascribe any role to these cells in the rather massive infiltration of
CD8-positive T cells and the subsequent pathogenic events that ensue in
the infected tissue. This observation is consistent with the results of
Stohlman and colleagues that show few CD4+ lymphocytes in
the parenchyma of mouse hepatitis virus-infected mouse brain
(54).
T cells normally enter the CNS only after they are activated by contact
with helper cells and viral antigen (24, 25, 72). In our
experiments, it is not clear where the infiltrating CD8-positive cells
were activated. It is unlikely that activation occurred at the
injection site because the inner compartment of the eye, like the CNS,
contains few lymphocytes and lacks lymphatic channels. Moreover, there
is an effective blood-eye barrier that precludes simple diffusion of
virus into the circulation (11, 44, 56). Only when this
barrier is breached would we expect lymphocytes to contact virus
(19, 49, 77). Even if T cells were to enter the eye, the
widespread expression of Fas ligand on ocular tissue should effectively
lead to Fas-mediated apoptosis of the invading lymphocytes (20,
21, 37). However, if virus in the inoculum leaked into the orbit
of the eye during injection, it might become accessible to immune cells
and activate them. Since we do find infection of oculomotor pathways
that innervate external ocular muscles, such a route is certainly
possible. Another possible site of T-cell activation may be in the deep
cervical lymph nodes that receive antigens from cerebrospinal fluid and
extracellular fluid of the brain (3, 12). Viral proteins
released from infected cells in the brain could be carried to these
deep lymph nodes, where T-cell activation could occur. Further work is
necessary to test these ideas.
Lymphocytes may be directed towards PRV infection sites in the brain by
signals from infected neurons or surrounding glial cells that become
reactive in response to infection. This idea is supported by studies
showing that the initial reactive response to PRV infection of
autonomic circuitry consists of a focal reactive response of astrocytes
and microglia at the infection site (6, 46). Astrocytes may
play an important role in leukocyte recruitment because they express
adhesion molecules and synthesize monocyte chemoattractant proteins
(29, 45). Through their extensive array of processes,
astrocytes are ideally situated to bridge the space between infected
neurons and the surrounding vasculature. Reactive glial responses, and
lymphocytes adhering to endothelial cells, may contribute to further
emigration and influx by secreting cytokines that promote increased
expression of adhesion molecules on the luminal surface of endothelial
cells (16, 38, 50). Given the short time period involved
before lymphocytes appear, the synergistic responses of glial and
endothelial cells (66) and the innate immune response to
infection are likely to be part of the signaling cascade that
stimulates the homing and extravasation of monocytes and T lymphocytes
from the vasculature into virus-infected sites.
There is a fundamental question of why the animals die several days
following virus injection, given the rather circumscribed sites of
viral pathology in the visual centers of the brain. Perhaps the influx
of lymphocytes and the attendant more-global immune-induced pathology
are responsible, rather than simply the loss of neurons. Another fundamental question concerns the molecular nature of the
signals from the infected cells that ultimately call in the leukocytes.
Less-virulent viruses will enable us to determine which viral or host
gene products are involved. For example, we have noted that gE and gI,
viral membrane proteins, play a role in virulence and neuropathology
(8, 60, 73).
In summary, our experiments show that CD45+ leukocytes
migrated through the vasculature and parenchyma in a focused response to a site-specific neurotropic virus infection in the CNS. Moreover, this recruitment into the CNS correlated with the extent of infection. The rapid and dynamic pattern of lymphocyte trafficking during viral
infection of the CNS supports the conclusion that there is immunologic
surveillance of the CNS (24, 25, 71, 72, 76). A better
understanding of the temporal organization of the trafficking of other
leukocytes into the CNS and the signaling cascade mediating leukocyte
recruitment will provide further insight into the mechanisms of
antiviral defense responses. Our ongoing studies employing this model
and isogenic PRV strains that differ in virulence will provide further
insight into the role of viral proteins in the neuroimmune response to
infection.
 |
ACKNOWLEDGMENTS |
We gratefully acknowledge William Chambers for his helpful
comments on this manuscript, Marlies Eldridge for growing and titering the stocks of PRV used in these studies, and Jared Marks for his expert
technical help with the CD4 staining.
This research was supported by National Institute of Health grants
MH01369 (S.R.), MH53574 (J.P.C.), NINDS33506 (L.W.E.), and MH484311
(A.F.S.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Neuroscience, 446 Crawford Hall, University of Pittsburgh, Pittsburgh, PA 15260. Phone: (412) 624-5571. Fax: (412) 624-9198. E-mail: stef+{at}pitt.edu.
 |
REFERENCES |
| 1.
|
Berke, G.
1995.
Unlocking the secrets of CTL and NK cells.
Immunol. Today
16:343-346[Medline].
|
| 2.
|
Bi, Z.,
M. Barna,
T. Komatsu, and C. S. Reiss.
1995.
Vesticular stomatitis virus infection of the central nervous system activates both innate and acquired immunity.
J. Virol.
69:6466-6472[Abstract].
|
| 3.
|
Bradbury, M. W. B.
1990.
Overview of passage routes of interstitial fluid to the lymphatics: history and current concepts, p. 413-420.
In
B. B. Johansson, C. Owman, and H. Widner (ed.), Pathophysiology of the brain-brain barrier. Elsevier, Oxford, United Kingdom.
|
| 4.
|
Burgert, H. G.
1996.
Subversion of the MHC class I antigen-presentation pathway by adenoviruses and herpes simplex viruses.
Trends Microbiol.
4:107-112[Medline].
|
| 5.
|
Card, J. P., and L. W. Enquist.
1994.
The use of pseudorabies virus for definition of synaptically linked populations of neurons, p. 363-382.
In
K. W. Adolph (ed.), Methods in molecular genetics. Academic Press Inc., Orlando, Fla.
|
| 6.
|
Card, J. P.,
L. Rinaman,
R. B. Lynn,
B. H. Lee,
R. P. Meade,
R. R. Miselis, and L. W. Enquist.
1993.
Pseudorabies virus infection of the rat central nervous system: ultrastructural characterization of viral replication, transport and pathogenesis.
J. Neurosci.
13:2515-2539[Abstract].
|
| 7.
|
Card, J. P.,
L. Rinaman,
J. S. Schwaber,
R. R. Miselis,
M. E. Whealy,
A. K. Robbins, and L. W. Enquist.
1990.
Neurotropic properties of pseudorabies virus: uptake and transneuronal passage in the rat central nervous system.
J. Neurosci.
10:1974-1994[Abstract].
|
| 8.
|
Card, J. P.,
M. E. Whealy,
A. K. Robbins, and L. W. Enquist.
1992.
Pseudorabies virus envelope glycoprotein gI influences both neurotropism and virulence during infection of the rat visual system.
J. Virol.
66:3032-3041[Abstract/Free Full Text].
|
| 9.
|
Card, J. P.,
M. E. Whealy,
A. K. Robbins,
R. Y. Moore, and L. W. Enquist.
1991.
Two -herpesvirus strains are transported differentially in the rodent visual system.
Neuron
6:957-969[Medline].
|
| 10.
|
Cassady, K., and R. Whitley.
1997.
Pathogenesis and pathophysiology of viral infections of the central nervous system, p. 7-22.
In
W. Scheld, R. J. Whitely, and D. Durack (ed.), Infections of the central nervous system. Lippincott-Raven, Philadelphia, Pa.
|
| 11.
|
Cousins, S. W., and R. D. Dix.
1997.
Immunology of the eye, p. 668-702.
In
R. W. Keane, and W. F. Hickey (ed.), Immunology of the nervous system. Oxford University Press, New York, N.Y.
|
| 12.
|
Cserr, H. F., and P. M. Knopf.
1992.
Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view.
Immunol. Today
13:507-512[Medline].
|
| 13.
|
Dijkstra, C. D.,
E. A. Dobb,
P. Joling, and G. Kraal.
1985.
The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3.
Immunology
54:589-599[Medline].
|
| 14.
|
Enquist, L. W., and J. P. Card.
1996.
Pseudorabies virus: a tool for tracing neuronal connections, p. 333-348.
In
P. R. Lowenstein, and L. W. Enquist (ed.), Protocols for gene transfer in neuroscience: towards gene therapy of neurological disorders. John Wiley & Sons Ltd., New York, N.Y.
|
| 15.
|
Enquist, L. W.,
J. Dubin,
M. E. Whealy, and J. P. Card.
1994.
Complementation analysis of pseudorabies virus gE and gI mutants in retinal ganglion cell neurotropism.
J. Virol.
68:5275-5279[Abstract/Free Full Text].
|
| 15a.
| Enquist, L. W., and R. Sparks-Thissen.
Unpublished observations.
|
| 16.
|
Fabry, Z.,
C. S. Raine, and M. N. Hart.
1994.
Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.
Immunol. Today
15:218-224[Medline].
|
| 17.
|
Gairin, J. E.,
E. Joly, and M. B. A. Oldstone.
1991.
Persistent infection with lymphocytic choriomeningitis virus enhances expression of MHC class I glycoprotein on cultured mouse brain endothelial cells.
J. Immunol.
146:3953-3957[Abstract].
|
| 18.
|
Gehrmann, J.,
Y. Matsumoto, and G. W. Kreutzberg.
1995.
Microglia: intrinsic immune effector cell of the brain.
Brain Res. Rev.
20:269-287[Medline].
|
| 19.
|
Geiger, K.,
E. Howes, and N. Sarvetnick.
1994.
Ectoptic expression of gamma interferon in the eye protects transgenic mice from intraocular herpes simplex virus type I infections.
J. Virol.
68:5556-5567[Abstract/Free Full Text].
|
| 20.
|
Griffith, T. S.,
T. Brunner,
S. M. Fletcher,
D. R. Green, and T. A. Ferguson.
1995.
Fas ligand-induced apoptosis as a mechanism of immune privilege.
Science
270:1189-1192[Abstract/Free Full Text].
|
| 21.
|
Griffith, T. S.,
X. Yu,
J. M. Herndon,
D. R. Green, and T. A. Ferguson.
1996.
CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance.
Immunity
5:7-16[Medline].
|
| 22.
|
Griffiths, G. M.
1995.
The cell biology of CTL killing.
Curr. Opin. Immunol.
17:343-348.
|
| 23.
|
Hickey, W.,
H. Lassmann, and A. Cross.
1997.
Lymphocyte entry and initiation of inflammation in the central nervous system, p. 200-225.
In
R. W. Keane, and W. F. Hickey (ed.), Immunology of the nervous system. Oxford University Press, New York, N.Y.
|
| 24.
|
Hickey, W. F.,
N. K. Gonatas,
H. Kimura, and D. B. Wilson.
1983.
Identification and quantitation of T lymphocyte subsets found in the spinal cord of the Lewis rat during acute experimental allergic encephalomyelitis.
J. Immunol.
131:2805-2809[Abstract].
|
| 25.
|
Hickey, W. F.,
B. L. Hsu, and H. Kiura.
1991.
T-lymphocyte entry into the central nervous system.
J. Neurosci. Res.
28:254-260[Medline].
|
| 26.
|
Hsu, S. M.,
L. Raine, and H. Fanger.
1981.
The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody procedures.
J. Histochem. Cytochem.
29:577-580[Abstract].
|
| 27.
|
Hudson, S., and J. Streilein.
1994.
Functional cytotoxic T cells are associated with focal lesions in the brains of SJL mice with experimental herpes simplex encephalitis.
J. Immunol.
152:5540-5547[Abstract].
|
| 28.
|
Huneycutt, B. S.,
Z. Bi,
C. J. Aoki, and C. S. Reiss.
1993.
Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice.
J. Virol.
67:6698-6706[Abstract/Free Full Text].
|
| 29.
|
Hurwitz, A. A.,
W. D. Lyman, and J. W. Berman.
1995.
Tumor necrosis factor alpha and transforming growth factor beta upregulate astrocyte expression of monocyte chemoattractant protein-1.
J. Neuroimmunol.
57:193-198[Medline].
|
| 30.
|
Jefferies, W. A.,
J. R. Green, and A. F. Williams.
1985.
Authentic T helper CD4 (W3/25) antigen on rat peritoneal macrophages.
J. Exp. Med.
162:117-127[Abstract/Free Full Text].
|
| 31.
|
Joly, E.,
L. Mucke, and M. B. A. Oldstone.
1991.
Viral persistence in neurons explained by lack of major histocompatibility complex class I expression.
Science
253:1283-1285[Abstract/Free Full Text].
|
| 32.
|
Joly, E., and M. B. A. Oldstone.
1992.
Neuronal cells are deficient in loading peptides onto MHC class I molecules.
Neuron
8:1185-1190[Medline].
|
| 33.
|
Kristensson, K.,
B. Svennerholm,
L. Persson,
A. Vahlne, and E. Lycke.
1979.
Latent HSV trigeminal ganglionic infection in mice and demyelination in the central nervous system.
J. Neurol. Sci.
43:253-263[Medline].
|
| 34.
|
Lewandowski, G., and M. V. Hobbs.
1998.
Evidence for deficiencies in intracerebral cytokine production, adhesion molecule induction, and T cell recruitment in herpes simplex virus type-2 infected mice.
J. Neuroimmunol.
81:58-65[Medline].
|
| 35.
|
Lewandowski, G.,
M. V. Hobbs, and F. E. Bloom.
1994.
Alteration of intracerebral cytokine production in mice infected with herpes simplex virus types 1 and 2.
J. Neuroimmunol.
55:23-34[Medline].
|
| 36.
|
Lewandowski, G. A.,
D. Lo, and F. E. Bloom.
1993.
Interference with major histocompatability complex class II restricted antigen presentation in the brain by herpes simplex virus type I: a possible mechanism of evasion of the immune response.
Proc. Natl. Acad. Sci. USA
90:2005-2009[Abstract/Free Full Text].
|
| 37.
|
Lynch, D. H.,
F. Ransdell, and M. R. Alderson.
1995.
Fas and FasL in the homeostatic regulation of immune responses.
Immunol. Today
16:569-574[Medline].
|
| 38.
|
Marker, O.,
A. Scheynius,
J. P. Christensen, and A. R. Thomsen.
1995.
Virus-activated T cells regulate expression of adhesion molecules on endothelial cells in sites of infection.
J. Neuroimmunol.
62:35-42[Medline].
|
| 39.
|
McLean, I. W., and P. K. Nakane.
1974.
Periodate-lysine-paraformaldehyde fixative. A new fixative for immunoelectron microscopy.
J. Histochem. Cytochem.
22:1077-1083[Abstract].
|
| 40.
|
Mellencamp, M. W.,
P. C. M. O'Brien, and J. R. Stevenson.
1991.
Pseudorabies virus-induced suppression of major histocampatibility complex class I antigen expression.
J. Virol.
65:3365-3368[Abstract/Free Full Text].
|
| 41.
|
Mucke, L., and M. B. A. Oldstone.
1992.
The expression of major histocompatibility complex (MHC) class I antigens in the brain differs markedly in acute and persistent infections with lymphocytic choriomeningitis virus (LCMV).
J. Neuroimmunol.
36:193-198[Medline].
|
| 42.
|
Niemialtowski, M., and B. T. Rouse.
1992.
Phenotypic and functional studies on ocular T cells during herpetic infections of the eye.
J. Immunol.
148:1864-1870[Abstract].
|
| 43.
|
Perry, H. V., and S. Gordon.
1987.
Modulation of CD4 antigen on macrophages and microglia in rat brain.
J. Exp. Med.
166:1138-1143[Abstract/Free Full Text].
|
| 44.
|
Rahi, A. H. S.
1984.
Immunopathology of the eye, p. 415-431.
In
P. Behan, and F. Spreafico (ed.), Neuroimmunology. Raven Press, New York, N.Y.
|
| 45.
|
Ransohoff, R. M.,
T. A. Hamilton,
M. Tani,
M. H. Stoler,
H. E. Shick,
J. A. Major,
M. L. Estes,
D. M. Thomas, and V. K. Tuohy.
1993.
Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis.
FASEB J.
7:592-600[Abstract].
|
| 46.
|
Rinaman, L.,
J. P. Card, and L. W. Enquist.
1993.
Spatiotemporal responses of astrocytes, ramified microglia, and brain macrophages to central neuronal infection with pseudorabies virus.
J. Neurosci.
13:685-702[Abstract].
|
| 47.
|
Rouse, B. T.
1996.
Virus-induced immunopathology.
Adv. Virus Res.
47:353-376[Medline].
|
| 48.
|
Sethna, M. P., and L. A. Lampson.
1991.
Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma.
J. Neuroimmunol.
34:121-132[Medline].
|
| 49.
|
Shimeld, C.,
J. L. Whiteland,
S. M. Nicholls,
D. L. Easty, and T. J. Hill.
1996.
Immune cell infiltration in corneas of mice with recurrent herpes simplex virus disease.
J. Gen. Virol.
77:977-985[Abstract/Free Full Text].
|
| 50.
|
Shimizu, Y.,
W. Newman,
Y. Tanaka, and S. Shaw.
1992.
Lymphocyte interactions with endothelial cells.
Immunol. Today
13:106-112[Medline].
|
| 51.
|
Simmons, A., and D. C. Tscharke.
1992.
Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons.
J. Exp. Med.
175:1337-1344[Abstract/Free Full Text].
|
| 52.
|
Sloan, D. J.,
M. J. Wood, and H. W. Charlton.
1992.
Leukocyte recruitment and inflammation in the CNS.
Trends Neurosci.
15:276-278[Medline].
|
| 53.
|
Sokal, R. R., and F. J. Rohlf.
1981.
Multiple and curvilinear regression, p. 671-683.
In
R. R. Sokal, and F. J. Rohlf (ed.), Biometry principles and practice of statistics in biological research. W. H. Freeman & Co., New York, N.Y.
|
| 54.
|
Stohlman, S. A.,
C. C. Bergmann,
M. T. Lin,
D. J. Cua, and D. R. Hinton.
1998.
CTL effector function within the central nervous system requires CD4+ cells.
J. Immunol.
160:2896-2904[Abstract/Free Full Text].
|
| 55.
|
Stohlman, S. A.,
S. Kyuwa,
J. M. Polo,
D. Brady,
M. M. C. Lai, and C. C. Bergmann.
1993.
Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain.
J. Virol.
67:7050-7059[Abstract/Free Full Text].
|
| 56.
|
Streilein, J. W., and A. W. Taylor.
1997.
Immunologic principles related to the nervous system and the eye: concerning the existence of a neural-ocular immune system, p. 99-133.
In
R. W. Keane, and W. F. Hickey (ed.), Immunology of the nervous system. Oxford University Press, New York, N.Y.
|
| 57.
|
Subak-Sharpe, I.,
H. Dyson, and J. Fazakerley.
1993.
In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection.
J. Virol.
67:7629-7633[Abstract/Free Full Text].
|
| 58.
|
Sussman, M. A.,
R. A. Shubin,
S. Kyuwa, and S. A. Stohlman.
1989.
T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system.
J. Virol.
63:3051-3056[Abstract/Free Full Text].
|
| 59.
|
Swanson, L. W.
1994.
Brain maps computer graphics files, 1.0 ed.
Elsevier Science, New York, N.Y.
|
| 60.
|
Tirabassi, R. S.,
R. A. Townley,
M. G. Eldridge, and L. W. Enquist.
1997.
Characterization of pseudorabies virus mutants expressing carboxy-terminal truncations of gE: evidence for envelope incorporation, virulence, and neurotropism domains.
J. Virol.
71:6455-6464[Abstract].
|
| 61.
|
Torres-Nagel, N.,
E. Kraus,
M. H. Brown,
G. Tiefenthaler,
R. Mitnacht,
A. F. Williams, and T. Hunig.
1992.
Differential thymus dependence of rat CD8 isoform expression.
Eur. J. Immunol.
22:2841-2848[Medline].
|
| 62.
|
Townsend, J. J.
1981.
The demyelinating effect of corneal HSV infections in normal and nude (athymic) mice.
J. Neurol. Sci.
50:435-441[Medline].
|
| 63.
|
Townsend, J. J.
1985.
Macrophage response to herpes simplex encephalitis in immune competent and T cell-deficient mice.
J. Neuroimmunol.
7:195-206[Medline].
|
| 64.
|
Townsend, J. J.
1981.
The relationship of astrocytes and macrophages to CNS demyelination after experimental herpes simplex virus infection.
J. Neuropathol. Exp. Neurol.
40:369-379[Medline].
|
| 65.
|
Townsend, J. J.
1983.
Schwann cell demyelination in experimental herpes simplex encephalitis at the trigeminal root entry zone.
J. Neuropathol. Exp. Neurol.
42:529-538[Medline].
|
| 66.
|
Vitkovic, L.,
A. D. Cunha, and W. R. Tyor.
1994.
Cytokine expression and pathogenesis in AIDS brain, p. 203-222.
In
R. W. Price, and S. W. Perry (ed.), HIV, AIDS and the brain. Raven Press, New York, N.Y.
|
| 67.
|
Wallgren, A. C.,
A. Karlsson-Parra, and O. Korsgren.
1995.
The main infiltrating cell in xenograft rejection is a CD4+ macrophage and not a T lymphocyte.
Transplantation
60:594-601[Medline].
|
| 68.
|
Wang, Y.,
V. L. Calder,
S. L. Lightman, and J. Greenwood.
1995.
Antigen presentation by rat brain and retinal endothelial cells.
J. Neuroimmunol.
61:231-239[Medline].
|
| 69.
|
Watson, R. E.,
S. T. Wiegand,
R. W. Clough, and G. E. Hoffman.
1986.
Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology.
Peptides
7:155-159[Medline].
|
| 70.
|
Weinstein, D. L.,
D. G. Walker,
H. Akiyama, and P. L. McGeer.
1990.
Herpes simplex virus type I infection of the CNS induces major histocompatibility complex antigen expression on rat microglia.
J. Neurosci. Res.
26:55-65[Medline].
|
| 71.
|
Wekerle, H.,
T. B. Engelhar,
W. Risau, and R. Meyermann.
1991.
Interaction of T lymphocytes with cerebral endothelial cells in vitro.
Brain Pathol.
1:107-114[Medline].
|
| 72.
|
Wekerle, H.,
C. Linington,
H. Lassmann, and R. Meyermann.
1986.
Cellular immune reactivity within the CNS.
Trends Neurosci.
9:271-277.
|
| 73.
|
Whealy, M. E.,
J. P. Card,
A. K. Robbins,
J. R. Dubin,
H. J. Rziha, and L. W. Enquist.
1993.
Specific pseudorabies virus infection of the rat visual system requires both gI and gp63 glycoproteins.
J. Virol.
67:3786-3797[Abstract/Free Full Text].
|
| 74.
|
Williamson, J. S. P., and S. A. Stohlman.
1990.
Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells.
J. Virol.
64:4589-4592[Abstract/Free Full Text].
|
| 75.
|
Williamson, J. S. P.,
K. C. Sykes, and S. A. Stohlman.
1991.
Characterization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM.
J. Neuroimmunol.
32:199-207[Medline].
|
| 76.
|
Wood, M. J.,
A. P. Byrnes,
S. D. Rabkin,
D. W. Pfaff, and H. M. Charlton.
1994.
Immunological consequences of HSV-1 mediated gene transfer into the CNS.
Gene Ther.
1:S82.
|
| 77.
|
Zaltas, M. M.,
M. Opremcak,
R. Hemady, and C. S. Foster.
1992.
Immunohistopathologic findings in herpes simplex virus chorioretinitis in the von Szily model.
Investig. Opthalmol. Vis. Sci.
33:68-77[Abstract/Free Full Text].
|
| 78.
|
Zuckermann, F. A.,
L. Zsak,
T. C. Mettenleitter, and T. Ben-Porat.
1990.
Pseudorabies virus glycoprotein gIII is a major target antigen for murine and swine virus-specific cytotoxic T lymphocytes.
J. Virol.
64:802-812[Abstract/Free Full Text].
|
Journal of Virology, November 1998, p. 9181-9191, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Paulus, C., Sollars, P. J., Pickard, G. E., Enquist, L. W.
(2006). Transcriptome Signature of Virulent and Attenuated Pseudorabies Virus-Infected Rodent Brain. J. Virol.
80: 1773-1786
[Abstract]
[Full Text]
-
Rinaman, L., Levitt, P., Card, J. P.
(2000). Progressive Postnatal Assembly of Limbic-Autonomic Circuits Revealed by Central Transneuronal Transport of Pseudorabies Virus. J. Neurosci.
20: 2731-2741
[Abstract]
[Full Text]
-
Gerdts, V., Beyer, J., Lomniczi, B., Mettenleiter, T. C.
(2000). Pseudorabies Virus Expressing Bovine Herpesvirus 1 Glycoprotein B Exhibits Altered Neurotropism and Increased Neurovirulence. J. Virol.
74: 817-827
[Abstract]
[Full Text]
-
Smith, G. A., Enquist, L. W.
(1999). Construction and Transposon Mutagenesis in Escherichia coli of a Full-Length Infectious Clone of Pseudorabies Virus, an Alphaherpesvirus. J. Virol.
73: 6405-6414
[Abstract]
[Full Text]